Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction

Sacubitril with valsartan (sacubitril/valsartan) is a relatively novel compound that has become a milestone in the treatment of patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF) in the last decade. Contemporary data suggest that sacubitril/valsartan is associated with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Mauro, Januzzi, James L, D’Elia, Emilia, Lorini, Ferdinando L, Senni, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054374/
https://www.ncbi.nlm.nih.gov/pubmed/33889425
http://dx.doi.org/10.15420/cfr.2020.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054374/
https://www.ncbi.nlm.nih.gov/pubmed/33889425
http://dx.doi.org/10.15420/cfr.2020.25

Ejemplares similares